Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AVXLANAVEX LIFE SCIENCES CORP.

Nasdaq · CIK 0001314052
Filer categoryLarge accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end0930
XBRL facts236

Identity from submissions API

NameANAVEX LIFE SCIENCES CORP.
CIK0001314052
TickersAVXL
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN980608404
LEI—
Fiscal year end0930
State of incorporation—
Phone844-689-3939
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Thrifty Printing Inc. (2005-01-13T00:00:00.000Z → 2007-01-25T00:00:00.000Z)
Business address
630 5TH AVENUE
20TH FLOOR
NEW YORK
NY
10111
NY
Mailing address
630 5TH AVENUE
20TH FLOOR
NEW YORK
NY
10111
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

638 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-06 4 xslF345X06/ownership.xml 0001731122-26-001421 5538
2026-11-06 4 xslF345X06/ownership.xml 0001731122-26-001419 5539
2026-11-06 4 xslF345X06/ownership.xml 0001731122-26-001417 5645
2026-11-06 4 xslF345X06/ownership.xml 0001731122-26-001411 1936745
2026-11-03 8-K FORM 8-K 5.02,9.01 0001731122-26-001395 001-37606 261514277 34 208137 1 1
2026-11-02 8-K FORM 8-K 5.02,8.01,9.01 0001731122-26-001392 001-37606 261512864 34 206517 1 1
2026-10-20 8-K FORM 8-K 8.01,9.01 0001731122-26-001351 001-37606 261472890 34 217008 1 1
2026-10-15 8-K FORM 8-K 8.01,9.01 0001731122-26-001348 001-37606 261463283 34 212367 1 1
2026-10-05 3 xslF345X06/ownership.xml 0001731122-26-001317 3167
2026-10-05 3 xslF345X06/ownership.xml 0001731122-26-001314 3147
2026-09-28 4 xslF345X06/ownership.xml 0001731122-26-001296 12978
2026-09-28 8-K FORM 8-K 5.01,5.07 0001731122-26-001294 001-37606 261418405 34 206878 1 1
2026-09-21 DFAN14A DFAN14A 0001493152-26-043435 001-37606 261392004 34 13151743
2026-09-18 DFAN14A DFAN14A 0001493152-26-043345 001-37606 261391000 34 48965
2026-09-17 DFAN14A DFAN14A 0001493152-26-043079 001-37606 261386068 34 75376
2026-09-15 DEFA14A FORM DEFA14A 0001731122-26-001244 001-37606 261381760 34 3555180
2026-09-15 DFAN14A DFAN14A 0001493152-26-042718 001-37606 261380240 34 61429
2026-09-14 DEFA14A FORM DEFA14A 0001731122-26-001235 001-37606 261375987 34 40731
2026-09-10 DFAN14A DFAN14A 0001493152-26-042192 001-37606 261371509 34 57403
2026-09-10 DFAN14A DFAN14A 0001493152-26-042019 001-37606 261369246 34 58473
2026-09-09 DFAN14A DFAN14A 0001493152-26-041997 001-37606 261368995 34 16046368
2026-09-09 8-K FORM 8-K 8.01 0001731122-26-001211 001-37606 261368950 34 184006 1 1
2026-09-08 DEFA14A FORM DEFA14A 0001731122-26-001207 001-37606 261365365 34 995135
2026-09-04 DEFA14A FORM DEFA14A 0001731122-26-001194 001-37606 261362322 34 642849
2026-09-04 DFAN14A DFAN14A 0001493152-26-041425 001-37606 261360003 34 217418
2026-09-03 DFAN14A DFAN14A 0001493152-26-041287 001-37606 261356360 34 16381904
2026-09-02 8-K FORM 8-K 8.01,9.01 0001731122-26-001179 001-37606 261355839 34 208053 1 1
2026-09-02 DFAN14A DFAN14A 0001493152-26-041140 001-37606 261352566 34 6177622
2026-09-01 DEFA14A FORM DEFA14A 0001731122-26-001175 001-37606 261350871 34 10764174
2026-08-31 DEFA14A FORM DEFA14A 0001731122-26-001171 001-37606 261342595 34 2341325
2026-08-28 10-Q FORM 10-Q 0001731122-26-001167 001-37606 261340732 34 3825409 1 1
2026-08-28 10-Q FORM 10-Q 0001731122-26-001166 001-37606 261340644 34 3647095 1 1
2026-08-28 10-Q/A FORM 10-Q/A 0001731122-26-001165 001-37606 261340605 34 284121 1 1
2026-08-28 10-K/A FORM 10-K/A 0001731122-26-001164 001-37606 261340585 34 4228368 1 1
2026-08-27 DEFC14A DEFC14A 0001493152-26-040438 001-37606 261331881 34 365159
2026-08-27 PRRN14A PRRN14A 0001493152-26-040286 001-37606 261324692 34 363813
2026-08-25 8-K FORM 8-K 2.02,9.01 0001731122-26-001143 001-37606 261312446 34 295692 1 1
2026-08-24 DEFA14A FORM DEFA14A 0001731122-26-001126 001-37606 261306363 34 7010925
2026-08-20 DFAN14A DFAN14A 0001493152-26-039269 001-37606 261296646 34 384869
2026-08-18 PRRN14A PRRN14A 0001493152-26-038835 001-37606 261288110 34 354306
2026-08-17 DEFA14A FORM DEFA14A 0001731122-26-001083 001-37606 261286683 34 901313
2026-08-17 DEFA14A FORM DEFA14A 0001731122-26-001080 001-37606 261284904 34 5714264
2026-08-17 8-K FORM 8-K 7.01,9.01 0001731122-26-001078 001-37606 261284864 34 5882437 1 1
2026-08-11 DEFA14A FORM DEFA14A 0001731122-26-001044 001-37606 261264463 34 74546
2026-08-11 8-K FORM 8-K 7.01,9.01 0001731122-26-001042 001-37606 261264230 34 247988 1 1
2026-08-11 DEFC14A FORM DEFC14A 0001731122-26-001038 001-37606 261260571 34 5824238
2026-08-10 NT 10-Q FORM NT 10-Q 0001731122-26-001031 001-37606 261259217 34 25648
2026-08-03 8-K FORM 8-K 7.01,9.01 0001731122-26-001000 001-37606 261230539 34 233871 1 1
2026-07-31 PREC14A FORM PREC14A 0001731122-26-000998 001-37606 261229485 34 2097213
2026-07-31 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001319 005-81767 261225836 34 7515
2026-07-30 8-K FORM 8-K 2.02,9.01 0001731122-26-000988 001-37606 261220324 34 279741 1 1
2026-07-24 PREC14A prec14a.htm 0000820434-26-000007 001-37606 261200045 34 51734
2026-07-20 8-K FORM 8-K 8.01 0001731122-26-000957 001-37606 261185292 34 184360 1 1
2026-06-26 8-K FORM 8-K 8.01 0001731122-26-000889 001-37606 261123786 34 191383 1 1
2026-05-22 8-K FORM 8-K 3.01,8.01,9.01 0001731122-26-000781 001-37606 261010834 34 207047 1 1
2026-05-15 8-K FORM 8-K 5.02 0001731122-26-000744 001-37606 26987723 34 184392 1 1
2026-05-14 3 xslF345X06/ownership.xml 0001731122-26-000722 6731
2026-05-11 NT 10-Q FORM NT 10-Q 0001731122-26-000702 001-37606 26963684 34 28496
2026-05-06 8-K FORM 8-K 5.02,9.01 0001731122-26-000678 001-37606 26945774 34 212005 1 1
2026-05-01 3 xslF345X06/ownership.xml 0001731122-26-000657 3105
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000679 005-81767 26797812 34 7255
2026-03-25 8-K FORM 8-K 8.01,9.01 0001731122-26-000482 001-37606 26792456 34 198779 1 1
2026-02-25 8-K FORM 8-K 5.02,7.01,9.01 0001731122-26-000305 001-37606 26674037 34 203652 1 1
2026-02-09 10-Q FORM 10-Q 0001731122-26-000200 001-37606 26612075 34 3366571 1 1
2026-02-09 8-K FORM 8-K 2.02,9.01 0001731122-26-000193 001-37606 26609607 34 269444 1 1
2026-01-09 4 xslF345X05/ownership.xml 0001731122-26-000036 5692
2026-01-09 4 xslF345X05/ownership.xml 0001731122-26-000035 5687
2025-11-25 10-K FORM 10-K 0001731122-25-001596 001-37606 251521783 34 7129889 1 1
2025-11-25 8-K FORM 8-K 2.02,9.01 0001731122-25-001591 001-37606 251515047 34 311644 1 1
2025-11-14 8-K FORM 8-K 8.01,9.01 0001731122-25-001536 001-37606 251481249 34 206901 1 1
2025-10-03 4 xslF345X05/ownership.xml 0001731122-25-001355 5692
2025-10-03 4 xslF345X05/ownership.xml 0001731122-25-001354 5695
2025-09-12 4 xslF345X05/ownership.xml 0001731122-25-001246 8864
2025-08-22 4 xslF345X05/ownership.xml 0001731122-25-001168 5699
2025-08-22 4 xslF345X05/ownership.xml 0001731122-25-001167 5704
2025-08-12 10-Q FORM 10-Q 0001731122-25-001105 001-37606 251206710 34 3442584 1 1
2025-07-28 8-K FORM 8-K 1.01,9.01 0001731122-25-001033 001-37606 251152751 34 476863 1 1
2025-07-25 424B5 FORM 424B5 0001731122-25-001025 333-288661 251152192 33 515572
2025-07-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002330 333-288661 251144387 33 1838
2025-07-21 CORRESP filename1.htm 0001731122-25-001001 7116
2025-07-21 UPLOAD filename1.pdf 0000000000-25-007655 333-288661 40210
2025-07-14 S-3 FORM S-3 0001731122-25-000973 333-288661 251122048 33 227829
2025-07-03 8-K FORM 8-K 5.02,9.01 0001731122-25-000935 001-37606 251106434 34 272564 1 1
2025-06-13 8-K FORM 8-K 5.02,5.07,9.01 0001731122-25-000878 001-37606 251047826 34 223289 1 1
2025-06-09 4 xslF345X05/ownership.xml 0001731122-25-000837 8925
2025-05-13 10-Q FORM 10-Q 0001731122-25-000724 001-37606 25940669 34 3384090 1 1
2025-04-30 4 xslF345X05/ownership.xml 0001731122-25-000655 5720
2025-04-30 4 xslF345X05/ownership.xml 0001731122-25-000654 5725
2025-04-25 ARS ARS 0001731122-25-000611 001-37606 25874807 34 2653443
2025-04-25 DEFA14A FORM DEFA14A 0001731122-25-000609 001-37606 25874733 34 1692679
2025-04-25 DEF 14A FORM DEF 14A 0001731122-25-000607 001-37606 25874610 34 4589949
2025-04-02 4 xslF345X05/ownership.xml 0001731122-25-000518 5354
2025-04-02 4 xslF345X05/ownership.xml 0001731122-25-000517 5373
2025-04-02 4 xslF345X05/ownership.xml 0001731122-25-000516 5344
2025-04-02 4 xslF345X05/ownership.xml 0001731122-25-000515 5329
2025-04-02 4 xslF345X05/ownership.xml 0001731122-25-000514 5353
2025-03-26 4 xslF345X05/ownership.xml 0001731122-25-000452 8881
2025-02-12 10-Q FORM 10-Q 0001731122-25-000205 001-37606 25612260 34 2806199 1 1
2025-01-17 4 xslF345X05/ownership.xml 0001731122-25-000096 8332
2025-01-17 4 xslF345X05/ownership.xml 0001731122-25-000095 5698
2024-12-23 4 xslF345X05/ownership.xml 0001731122-24-002045 5770
2024-12-23 4 xslF345X05/ownership.xml 0001731122-24-002044 5773
2024-12-23 10-K FORM 10-K 0001731122-24-002041 001-37606 241574057 34 5505180 1 1
2024-12-06 4 xslF345X05/ownership.xml 0001731122-24-001953 5813
2024-12-06 4 xslF345X05/ownership.xml 0001731122-24-001952 5810
2024-08-06 10-Q FORM 10-Q 0001731122-24-001207 001-37606 241180566 34 3632467 1 1
2024-07-30 8-K FORM 8-K 1.02 0001731122-24-001160 001-37606 241158922 34 196234 1 1
2024-07-29 S-3 FORM S-3 0001731122-24-001154 333-281089 241153491 33 292757
2024-06-21 8-K FORM 8-K 5.07 0001731122-24-001003 001-37606 241060902 34 207016 1 1
2024-06-17 4 xslF345X05/ownership.xml 0001731122-24-000957 4785
2024-05-17 4 xslF345X05/ownership.xml 0001731122-24-000828 4758
2024-05-09 10-Q FORM 10-Q 0001731122-24-000760 001-37606 24931371 34 3485019 1 1
2024-05-09 8-K FORM 8-K 2.02,9.01 0001731122-24-000758 001-37606 24928672 34 286392 1 1
2024-05-06 DEFA14A FORM DEFA14A 0001731122-24-000732 001-37606 24915396 34 2846519
2024-05-06 DEF 14A FORM DEF 14A 0001731122-24-000730 001-37606 24915384 34 1870710
2024-04-01 4 xslF345X05/ownership.xml 0001731122-24-000552 8811
2024-03-28 144 xsl144X01/primary_doc.xml 0001949846-24-000179 001-37606 24793712 33 4281
2024-02-23 4 xslF345X05/ownership.xml 0001731122-24-000297 5395
2024-02-23 4 xslF345X05/ownership.xml 0001731122-24-000295 5370
2024-02-23 4 xslF345X05/ownership.xml 0001731122-24-000296 5394
2024-02-23 4 xslF345X05/ownership.xml 0001731122-24-000294 5414
2024-02-23 4 xslF345X05/ownership.xml 0001731122-24-000293 5385
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020285 005-81767 24627364 34 13144
2024-02-07 10-Q FORM 10-Q 0001731122-24-000206 001-37606 24604761 34 3012187 1 1
2024-01-25 SC 13G/A us0327973006_012524.txt 0001086364-24-003825 005-81767 24563068 34 13701
2024-01-22 SC 13G/A Anavex_Life_Sc_Corp.txt 0000093751-24-000048 005-81767 24547558 34 8533
2024-01-12 4 xslF345X05/ownership.xml 0001731122-24-000070 5742
2024-01-12 4 xslF345X05/ownership.xml 0001731122-24-000069 5739
2023-11-27 10-K FORM 10-K 0001731122-23-002197 001-37606 231440632 34 6316302 1 1
2023-08-08 10-Q FORM 10-Q 0001731122-23-001412 001-37606 231151919 34 3335449 1 1
2023-06-30 4 xslF345X04/ownership.xml 0001731122-23-001246 12377
2023-06-28 144 xsl144X01/primary_doc.xml 0001949846-23-000171 001-37606 231050675 33 4241
2023-05-24 8-K FORM 8-K 5.07 0001731122-23-001007 001-37606 23954556 34 201347 1 1
2023-05-09 10-Q FORM 10-Q 0001731122-23-000845 001-37606 23902635 34 3080750 1 1
2023-04-14 8-K FORM 8-K 5.03,9.01 0001731122-23-000651 001-37606 23819602 34 287190 1 1
2023-04-04 4 xslF345X04/ownership.xml 0001731122-23-000585 5375
2023-04-04 4 xslF345X04/ownership.xml 0001731122-23-000584 5331
2023-04-04 4 xslF345X04/ownership.xml 0001731122-23-000583 5356
2023-04-04 4 xslF345X04/ownership.xml 0001731122-23-000582 5356
2023-04-04 4 xslF345X04/ownership.xml 0001731122-23-000581 5346
2023-04-04 DEFA14A FORM DEFA14A 0001731122-23-000575 001-37606 23798425 34 6154581
2023-04-04 DEF 14A FORM DEF 14A 0001731122-23-000573 001-37606 23798322 34 3206378
2023-03-13 8-K FORM 8-K 7.01 0001731122-23-000348 001-37606 23725182 34 196123 1 1
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015308 005-81767 23602392 34 13108
2023-02-09 SC 13G/A Anavex_Life_Sciences_Corp.txt 0000093751-23-000386 005-81767 23601871 34 10443
2023-02-07 8-K FORM 8-K 8.01,9.01 0001731122-23-000156 001-37606 23596123 34 220720 1 1
2023-02-07 424B5 FORM 424B5 0001731122-23-000154 333-259788 23596086 33 348972
2023-02-07 10-Q FORM 10-Q 0001731122-23-000152 001-37606 23596033 34 3221839 1 1
2023-01-31 SC 13G/A us0327973006_013123.txt 0001306550-23-005072 005-81767 23571738 34 13493
2023-01-27 10-K/A FORM 10-K/A 0001731122-23-000089 001-37606 23564438 34 430745
2022-12-02 8-K FORM 8-K 8.01,9.01 0001731122-22-002078 001-37606 221440300 34 227927 1 1
2022-11-28 10-K FORM 10-K 0001731122-22-002062 001-37606 221426387 34 5339370 1 1
2022-08-12 UPLOAD filename1.pdf 0000000000-22-008612 39576
2022-08-10 CORRESP filename1.htm 0001731122-22-001310 14535
2022-08-09 10-Q FORM 10-Q 0001731122-22-001301 001-37606 221148849 34 3358648 1 1
2022-07-29 UPLOAD filename1.pdf 0000000000-22-007984 43006
2022-06-29 4 xslF345X03/ownership.xml 0001731122-22-001150 5152
2022-06-29 4 xslF345X03/ownership.xml 0001731122-22-001147 5128
2022-06-29 4 xslF345X03/ownership.xml 0001731122-22-001145 5153
2022-06-29 4 xslF345X03/ownership.xml 0001731122-22-001143 5143
2022-06-29 4 xslF345X03/ownership.xml 0001731122-22-001141 5167
2022-06-10 S-8 FORM S-8 0001731122-22-001056 333-265537 221009806 33 114168
2022-05-27 4 xslF345X03/ownership.xml 0001731122-22-001013 8315
2022-05-27 8-K FORM 8-K 5.07 0001731122-22-001011 001-37606 22978124 34 205828 1 1
2022-05-10 10-Q FORM 10-Q 0001731122-22-000851 001-37606 22910209 34 3373649 1 1
2022-04-11 DEFA14A FORM DEFA14A 0001731122-22-000705 001-37606 22820378 34 1195046
2022-04-11 DEF 14A FORM DEF 14A 0001731122-22-000703 001-37606 22820328 34 1453441
2022-04-08 8-K FORM 8-K 5.02,9.01 0001731122-22-000700 001-37606 22817395 34 225317 1 1
2022-03-04 8-K FORM 8-K 4.01,5.02,7.01,9.01 0001731122-22-000366 001-37606 22712064 34 249764 1 1
2022-02-09 SC 13G ANAVEX_LIFE_SCIENCES_CORP.txt 0000093751-22-000053 005-81767 22608244 34 8516
2022-02-09 10-Q FORM 10-Q 0001731122-22-000196 001-37606 22607648 34 3071943 1 1
2022-02-09 SC 13G SCHEDULE 13G 0001104659-22-016484 005-81767 22606380 34 13074
2022-02-04 8-K FORM 8-K 8.01,9.01 0001731122-22-000164 001-37606 22590987 34 212685 1 1
2022-02-03 SC 13G/A us0327973006_020222.txt 0000834237-22-005301 005-81767 22585577 34 13526
2022-02-02 8-K FORM 8-K 7.01,9.01 0001731122-22-000148 001-37606 22581600 34 33262851 1 1
2021-11-24 10-K FORM 10-K 0001731122-21-002062 001-37606 211447248 34 13781343 1 1
2021-09-27 8-K FORM 8-K 8.01,9.01 0001731122-21-001568 001-37606 211279025 34 215751 1 1
2021-09-24 S-3ASR FORM S-3ASR 0001731122-21-001562 333-259788 211278102 33 525248
2021-09-13 8-K FORM 8-K 7.01,9.01 0001731122-21-001498 001-37606 211248615 34 17635223
2021-08-12 10-Q FORM 10-Q 0001731122-21-001347 001-37606 211168676 34 3216725 1 1
2021-08-04 4 xslF345X03/ownership.xml 0001731122-21-001306 5177
2021-08-04 4 xslF345X03/ownership.xml 0001731122-21-001304 5156
2021-08-04 4 xslF345X03/ownership.xml 0001731122-21-001302 5330
2021-08-04 4 xslF345X03/ownership.xml 0001731122-21-001300 5158
2021-08-04 4 xslF345X03/ownership.xml 0001731122-21-001296 5133
2021-08-04 4 xslF345X03/ownership.xml 0001731122-21-001294 5148
2021-08-04 4 xslF345X03/ownership.xml 0001731122-21-001292 5342
2021-07-01 4 xslF345X03/ownership.xml 0001731122-21-001127 8354
2021-07-01 4 xslF345X03/ownership.xml 0001731122-21-001126 15696
2021-06-24 8-K FORM 8-K 1.01,9.01 0001731122-21-001090 001-37606 211043079 34 591952 1 1
2021-06-24 424B5 FORM 424B5 0001731122-21-001084 333-232550 211040845 33 273725
2021-06-09 3 xslF345X02/ownership.xml 0001731122-21-001022 4446
2021-05-28 8-K 8-K 5.03,5.07,9.01 0001731122-21-000974 001-37606 21979983 34 1351623 1 1
2021-05-25 4 xslF345X03/ownership.xml 0001731122-21-000941 33351
2021-05-19 4 xslF345X03/ownership.xml 0001731122-21-000916 4512
2021-05-13 10-Q 10-Q 0001731122-21-000829 001-37606 21920081 34 1986303 1
2021-04-12 DEF 14A DEF 14A 0001731122-21-000572 001-37606 21820797 34 2370631
2021-04-09 S-8 e2594_s8.htm 0001731122-21-000561 333-255166 21818485 33 73125
2021-04-01 PRE 14A PRELIMINARY INFORMATION STATEMENT 0001731122-21-000497 001-37606 21798022 34 2345206
2021-02-26 4 FORM 4 0001731122-21-000308 11987
2021-02-23 4 FORM 4 0001731122-21-000286 6015
2021-02-16 424B5 424B5 0001731122-21-000269 333-232550 21641072 33 310165
2021-02-16 10-Q FORM 10-Q 0001731122-21-000261 001-37606 21639446 34 2948923 1 1
2021-02-16 SC 13G/A SC 13G/A 0000905718-21-000240 005-81767 21637893 34 66896
2021-02-02 SC 13G us0327973006_020221.txt 0000834237-21-006935 005-81767 21580644 34 13234
2021-01-04 4 FORM 4 0001731122-21-000016 5166
2021-01-04 4 FORM 4 0001731122-21-000014 5151
2021-01-04 4 FORM 4 0001731122-21-000012 5448
2021-01-04 4 FORM 4 0001731122-21-000010 5176
2021-01-04 4 FORM 4 0001731122-21-000008 5167
2021-01-04 4 FORM 4 0001731122-21-000006 5175
2021-01-04 4 FORM 4 0001731122-21-000004 5454
2020-12-28 8-K FORM 8-K 2.02,9.01 0001731122-20-001339 001-37606 201419267 34 75532
2020-12-28 10-K FORM 10-K 0001731122-20-001338 001-37606 201419254 34 3777492 1 1
2020-12-15 8-K FORM 8-K 7.01,8.01,9.01 0001731122-20-001291 001-37606 201388196 34 53998
2020-11-06 8-K FORM 8-K 8.01,9.01 0001731122-20-001114 001-37606 201293027 34 9450539
2020-10-15 8-K FORM 8-K 7.01,8.01,9.01 0001731122-20-001047 001-37606 201240300 34 51266
2020-08-06 10-Q FORM 10-Q 0001731122-20-000807 001-37606 201081634 34 2675593 1 1
2020-07-02 8-K FORM 8-K 1.01,9.01 0001731122-20-000712 001-37606 201010934 34 46687
2020-07-02 424B5 424B5 0001731122-20-000711 333-232550 201010925 33 309604
2020-05-07 10-Q FORM 10-Q 0001731122-20-000447 001-37606 20856984 34 2353437 1
2020-05-01 8-K FORM 8-K 1.01,8.01,9.01 0001731122-20-000432 001-37606 20838324 34 297400
2020-05-01 424B5 424B5 0001731122-20-000431 333-232550 20838323 33 322339
2020-05-01 424B5 424B5 0001731122-20-000430 333-232550 20838302 33 294718
2020-04-08 8-K FORM 8-K 5.07 0001731122-20-000360 001-37606 20782259 34 22021
2020-03-23 DEFA14A DEFA14A 0001731122-20-000289 001-37606 20733625 34 13097
2020-03-09 SC 13G/A us0327973006_030920.txt 0000834237-20-009195 005-81767 20698299 34 12320
2020-02-20 DEF 14A DEF 14A 0001731122-20-000195 001-37606 20635606 34 1072062
2020-02-14 SC 13G/A SC 13G/A 0000905718-20-000234 005-81767 20620114 34 67555
2020-02-07 SC 13G us0327973006_020620.txt 0000834237-20-008231 005-81767 20584867 34 13191
2020-02-06 10-Q FORM 10-Q 0001731122-20-000103 001-37606 20583700 34 2037484 1
2020-01-08 4 xslF345X03/ownership.xml 0001731122-20-000024 5427
2020-01-08 4 xslF345X03/ownership.xml 0001731122-20-000023 5154
2020-01-08 4 xslF345X03/ownership.xml 0001731122-20-000022 5130
2020-01-08 4 xslF345X03/ownership.xml 0001731122-20-000021 5431
2020-01-08 4 xslF345X03/ownership.xml 0001731122-20-000020 5146
2020-01-08 4 xslF345X03/ownership.xml 0001731122-20-000019 5155
2020-01-08 4 xslF345X03/ownership.xml 0001731122-20-000018 5145
2019-12-16 10-K FORM 10-K 0001731122-19-000784 001-37606 191288046 34 3358034 1
2019-09-20 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001213900-19-018310,2019-09-20 9999999995-19-002138 333-207600 191106193 33 1858
2019-09-17 POS AM FORM POS AM 0001213900-19-018310 333-207600 191097723 33 20277
2019-09-16 AW AW 0001213900-19-018132 333-207600 191094901 NE 6745
2019-09-13 8-K CURRENT REPORT 8.01,9.01 0001213900-19-018023 001-37606 191093200 34 25469
2019-09-13 424B5 PROSPECTUS SUPPLEMENT 0001213900-19-018012 333-232550 191093169 33 286047
2019-09-13 S-3/A AMENDMENT NO. 4 TO FORM S-3 0001213900-19-018007 333-207600 191093135 33 22525
2019-08-07 10-Q QUARTERLY REPORT 0001213900-19-014791 001-37606 191005468 34 1811462 1
2019-07-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-07-15 16:00:00 9999999995-19-001606 333-232550 19956162 33 1844
2019-07-12 CORRESP filename1.htm 0001213900-19-012578 6436
2019-07-11 UPLOAD filename1.pdf 0000000000-19-011025 46160
2019-07-03 S-3 REGISTRATION STATEMENT 0001213900-19-012072 333-232550 19942278 33 235491
2019-06-12 424B5 PROSPECTUS SUPPLEMENT 0001213900-19-010604 333-207600 19894167 33 341798
2019-06-12 8-K CURRENT REPORT 1.01,9.01 0001213900-19-010601 001-37606 19894139 34 381890
2019-06-06 4 4 0001213900-19-010249 5447
2019-05-09 10-Q FORM 10-Q 0001615774-19-007324 001-37606 19808419 34 3428999 1
2019-05-07 4 FORM 4 0001615774-19-007213 5370
2019-04-08 8-K 8-K 5.07 0001615774-19-005452 001-37606 19737764 34 31966
2019-03-18 8-K FORM 8-K 8.01,9.01 0001615774-19-004139 001-37606 19686737 34 22026
2019-03-18 424B5 424B5 0001615774-19-004136 333-207600 19686556 33 439903
2019-02-14 SC 13G/A ANAVEX LIFE AMENDMENT NO. 2 0000905718-19-000231 005-81767 19607766 34 76520
2019-02-11 DEF 14A DEF 14A 0001615774-19-002242 001-37606 19585497 34 1749950
2019-02-07 10-Q 10-Q 0001615774-19-002057 001-37606 19575553 34 2664238 1
2019-01-31 PRE 14A PRE 14A 0001615774-19-001498 001-37606 19556245 34 1713270
2019-01-25 10-K/A FORM 10-K/A 0001615774-19-001031 001-37606 19543211 34 3379834 1
2018-12-12 10-K FORM 10-K 0001615774-18-014328 001-37606 181231244 34 4564176 1
2018-10-09 4 4 0001615774-18-010620 5376
2018-10-03 4 FORM 4 0001615774-18-010447 5383
2018-10-03 4 FORM 4 0001615774-18-010445 5380
2018-10-03 4 FORM 4 0001615774-18-010443 5414
2018-10-03 4 FORM 4 0001615774-18-010441 5366
2018-10-03 4 FORM 4 0001615774-18-010439 5410
2018-10-03 4 FORM 4 0001615774-18-010436 5391
2018-08-09 10-Q 10-Q 0001615774-18-007805 001-37606 181005527 34 2778079 1
2018-07-06 8-K 8-K 1.01,9.01 0001615774-18-006280 001-37606 18942974 34 279140
2018-07-06 424B5 424B5. 0001615774-18-006278 333-207600 18942964 33 463579
2018-05-17 4 4 0001615774-18-004023 5377
2018-05-17 4 4 0001615774-18-004019 5378
2018-05-10 10-Q 10-Q 0001615774-18-003574 001-37606 18823015 34 2465923 1
2018-04-24 3 3 0001615774-18-002846 4486
2018-04-20 8-K 8-K 5.07 0001615774-18-002786 001-37606 18767106 34 20039
2018-03-09 4 4 0001615774-18-001744 4792
2018-03-08 8-K 8-K 5.02,8.01,9.01 0001615774-18-001701 001-37606 18677262 34 30165
2018-03-08 DEF 14A DEF 14A 0001615774-18-001673 001-37606 18674797 34 453935
2018-03-07 4 4 0001615774-18-001650 4793
2018-03-06 4 4 0001615774-18-001629 4797
2018-03-05 4 FORM 4 0001615774-18-001587 4808
2018-02-14 SC 13G/A AMENDMENT NO. 1 0000905718-18-000242 005-81767 18613209 34 85731
2018-02-07 10-Q 10-Q 0001615774-18-000934 001-37606 18581820 34 2462274 1
2017-12-15 4 OWNERSHIP DOCUMENT 0001615774-17-007357 5356
2017-12-15 4 4 0001615774-17-007355 5353
2017-12-11 10-K 10-K 0001615774-17-007272 001-37606 171250250 34 4256031 1
2017-10-26 4 OWNERSHIP DOCUMENT 0001615774-17-005929 4818
2017-10-24 4 4 0001615774-17-005861 4801
2017-10-19 4 4 0001615774-17-005807 4801
2017-10-18 4 4 0001615774-17-005767 4801
2017-10-16 4 4 0001615774-17-005731 4801
2017-10-06 8-K 8-K 5.02 0001615774-17-005634 001-37606 171128064 34 12852
2017-10-05 4 4 0001615774-17-005604 4801
2017-10-02 4 4 0001615774-17-005508 4801
2017-09-29 4 4 0001615774-17-005440 4801
2017-09-26 4 4 0001615774-17-005351 4801
2017-09-20 4 4 0001615774-17-005226 4797
2017-09-19 4 4 0001615774-17-005183 4797
2017-09-14 4 4 0001615774-17-005088 4797
2017-09-11 4 4 0001615774-17-005014 4797
2017-09-08 4 4 0001615774-17-004994 4797
2017-09-07 424B3 424B3 0001615774-17-004964 333-218292 171073758 33 182698
2017-09-05 4 4 0001615774-17-004918 4792
2017-08-31 4 4 0001615774-17-004886 4792
2017-08-29 4 4 0001615774-17-004809 4801
2017-08-25 4 4 0001615774-17-004745 4801
2017-08-21 4 4 0001615774-17-004587 4801
2017-08-18 4 4 0001615774-17-004574 4801
2017-08-14 4 4 0001615774-17-004399 4801
2017-08-11 S-8 S-8 0001615774-17-004290 333-219934 171026098 33 71580
2017-08-11 4 4 0001615774-17-004281 4788
2017-08-07 10-Q 10-Q 0001615774-17-004118 001-37606 171012029 34 2393539 1
2017-06-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2017-06-12 16:00:00 9999999995-17-001508 333-218292 17907877 33 1844
2017-06-09 CORRESP filename1.htm 0001615774-17-003075 6751
2017-06-09 UPLOAD filename1.pdf 0000000000-17-020197 36537
2017-05-26 S-3 S-3 0001615774-17-002760 333-218292 17874379 33 253819
2017-05-15 4 OWNERSHIP DOCUMENT 0001615774-17-002453 5357
2017-05-15 4 OWNERSHIP DOCUMENT 0001615774-17-002450 5354
2017-05-10 10-Q QUARTERLY REPORT 0001615774-17-002182 001-37606 17830660 34 2297033 1
2017-04-21 8-K 8-K 5.07 0001615774-17-001794 001-37606 17774149 34 24801
2017-03-17 DEFA14A DEFA14A 0001615774-17-001113 001-37606 17696224 34 66893
2017-03-10 DEF 14A DEF 14A 0001615774-17-000957 001-37606 17680122 34 666183
2017-02-27 PRE 14A PRE 14A 0001615774-17-000809 001-37606 17642227 34 1085029
2017-02-16 3 3 0001615774-17-000682 4266
2017-02-13 SC 13G l29170sc13g.htm 0001214659-17-001035 005-81767 17600191 34 74187
2017-02-13 8-K 8-K 5.02,9.01 0001615774-17-000519 001-37606 17596143 34 29226
2017-02-07 10-Q 10-Q 0001615774-17-000400 001-37606 17579454 34 2177411 1
2016-12-14 10-K 10-K 0001615774-16-008914 001-37606 162051202 34 4617087 1
2016-10-21 8-K 8-K 7.01,9.01 0001615774-16-007701 001-37606 161945849 34 44113
2016-09-26 4 4 0001615774-16-007390 5162
2016-09-26 4 4 0001615774-16-007388 5163
2016-09-26 4 4 0001615774-16-007386 5165
2016-09-26 4 4 0001615774-16-007384 5148
2016-09-26 4 4 0001615774-16-007380 5194
2016-09-26 4 4 0001615774-16-007378 5197
2016-09-12 424B3 424B3 0001615774-16-007133 333-207600 161881450 33 376493
2016-09-06 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2016-09-06 16:00:00 9999999995-16-005616 333-207600 161872142 33 1845
2016-09-01 CORRESP filename1.htm 0001615774-16-007018 8933
2016-08-31 S-3/A S-3/A 0001615774-16-007004 333-207600 161864031 33 503178
2016-08-30 CORRESP filename1.htm 0001615774-16-006997 12475
2016-08-30 UPLOAD filename1.pdf 0000000000-16-090644 137596
2016-08-26 S-3/A S-3/A 0001615774-16-006972 333-207600 161855574 33 554827
2016-08-25 UPLOAD filename1.pdf 0000000000-16-090046 139968
2016-08-18 S-3/A S-3/A 0001615774-16-006875 333-207600 161841542 33 826505
2016-08-11 10-Q 10-Q 0001615774-16-006697 001-37606 161825022 34 2699899 1
2016-07-22 8-K FORM 8-K 5.02,9.01 0001615774-16-006410 001-37606 161780297 34 133801
2016-07-19 4 OWNERSHIP DOCUMENT 0001615774-16-006375 8301
2016-07-07 8-K FORM 8-K 5.02,9.01 0001615774-16-006259 001-37606 161757244 34 134172
2016-07-05 4 4 0001615774-16-006190 5541
2016-06-23 8-K 8-K 7.01,9.01 0001615774-16-006051 001-37606 161729167 34 9912091
2016-05-11 10-Q FORM 10-Q 0001615774-16-005331 001-37606 161640402 34 3064042 1
2016-05-11 8-K FORM 8-K 5.02,5.07 0001615774-16-005297 001-37606 161637234 34 19712
2016-05-06 8-K 8-K 7.01,9.01 0001615774-16-005236 001-37606 161626313 34 11478870 1
2016-05-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001615774-16-005167 7705
2016-05-02 4/A STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001615774-16-005165 8261
2016-04-18 4 4 0001615774-16-005015 5601
2016-04-18 4 4 0001615774-16-005013 5605
2016-04-01 DEF 14A DEF 14A 0001615774-16-004771 001-37606 161547877 34 481364
2016-02-23 4 OWNERSHIP DOCUMENT 0001615774-16-004291 8913
2016-02-16 SC 13G dafna13gAVXL2015.txt 0001389933-16-000024 005-81767 161421636 34 10279
2016-02-08 10-Q 10-Q 0001615774-16-004126 001-37606 161394596 34 3065244 1
2015-12-29 10-K FORM 10-K 0001615774-15-003756 001-37606 151310277 34 5259421 1
2015-11-23 UPLOAD filename1.pdf 0000000000-15-055043 166734
2015-11-16 5 5 0001615774-15-003321 8364
2015-10-26 8-K FORM 8-K 1.01,3.02,9.01 0001615774-15-003021 001-37606 151174323 34 243729
2015-10-26 S-3 FORM S-3 0001615774-15-003018 333-207600 151174315 33 183323
2015-10-23 CERTNAS AUTO-GENERATED PAPER DOCUMENT 9999999997-15-014269 001-37606 15008231 34 1449
2015-10-23 8-A12B FORM 8-A12B 0001062993-15-005564 001-37606 151172280 34 6411
2015-10-09 3 3 0001615774-15-002893 5750
2015-10-07 8-K/A FORM 8-K/A 3.03,5.02,5.03,9.01 0001062993-15-005302 000-51652 151147633 34 20555
2015-10-06 8-K FORM 8-K 3.03,5.02,5.03,9.01 0001062993-15-005296 000-51652 151146166 34 36600
2015-09-28 8-K FORM 8-K 7.01,9.01 0001062993-15-005193 000-51652 151126679 34 22769
2015-08-14 10-Q FORM 10-Q 0001062993-15-004580 000-51652 151055862 34 4311965 1
2015-07-23 8-K FORM 8-K 7.01,9.01 0001062993-15-003999 000-51652 151002335 34 26471
2015-07-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-15-003849 4878
2015-07-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-15-003846 4879
2015-07-08 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001062993-15-003474,2015-07-08 9999999995-15-001857 333-191682 15980381 33 1857
2015-07-08 424B3 FORM 424B3 0001062993-15-003758 333-191682 15978759 33 816196
2015-07-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-15-003743 6324
2015-07-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-15-003645 6469
2015-06-25 3 3 0001615774-15-001605 4283
2015-06-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-15-003522 5022
2015-06-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-15-003506 5023
2015-06-19 POS AM FORM POS AM 0001062993-15-003474 333-191682 15943068 33 11776019 1
2015-06-17 8-K FORM 8-K 5.02 0001062993-15-003421 000-51652 15937625 34 6176
2015-06-16 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-15-003409 5023
2015-06-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-15-003384 5023
2015-06-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-15-003350 5027
2015-06-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-15-003272 5027
2015-06-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-15-003244 5027
2015-05-29 8-K FORM 8-K 7.01,9.01 0001062993-15-003139 000-51652 15899945 34 20931
2015-05-14 10-Q FORM 10-Q 0001062993-15-002741 000-51652 15863660 34 4886992 1
2015-03-30 8-K FORM 8-K 5.03,5.07,9.01 0001062993-15-001619 000-51652 15735467 34 30335
2015-03-25 424B3 FORM 424B3 0001062993-15-001458 333-202533 15723114 33 868184
2015-03-24 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2015-03-24 12:00:00 9999999995-15-000682 333-202533 15723187 33 1844
2015-03-05 S-1 FORM S-1 0001062993-15-001191 333-202533 15678320 33 11802967 1

Latest XBRL company facts

One latest value per concept from companyfacts (236 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 92.70M 2026-08-28 2026 Q2 10-Q 2026-08-28 0001731122-26-001166
dei EntityPublicFloat Entity Public Float USD 708.00M 2025-03-31 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 800,000 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.66M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap AccretionExpense Accretion Expense USD 5,830 2015-10-01 2016-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 718,000 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 4.04M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 7.33M 2024-06-30 2024 Q3 10-Q 2024-08-06 0001731122-24-001207
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 65.03M 2015-06-30 2015 Q3 10-Q 2015-08-14 0001062993-15-004580
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 498.00M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 2.61M 2013-10-01 2014-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 221,000 2013-10-01 2014-09-30 2014 FY 10-K 2014-12-29 0001062993-14-007294
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.42M 2025-10-01 2026-03-31 2026 Q2 10-Q 2026-08-28 0001731122-26-001166
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 4.45M 2015-10-01 2016-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 2,452 2013-10-01 2014-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 5.99M 2013-10-01 2014-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 15.70M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 1.12M 2013-10-01 2014-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 14.97M 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap Assets Assets USD 120.14M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap AssetsCurrent Assets, Current USD 31.63M 2020-06-30 2020 Q3 10-Q 2020-08-06 0001731122-20-000807
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 85,243 2022-10-01 2023-06-30 2023 Q3 10-Q 2023-08-08 0001731122-23-001412
us-gaap Cash Cash USD 149.16M 2022-09-30 2022 FY 10-K 2022-11-28 0001731122-22-002062
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 118.33M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 18.11M 2020-10-01 2020-12-31 2021 Q1 10-Q 2021-02-16 0001731122-21-000261
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 118.33M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 15.75M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2025-09-30 2025 FY 10-K 2025-11-25 0001731122-25-001596
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD -745,008 2018-10-01 2019-09-30 2019 FY 10-K 2019-12-16 0001731122-19-000784
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 10,000 2026-03-31 2026 Q2 10-Q 2026-08-28 0001731122-26-001166
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 14.00M 2025-04-17 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 92.70M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 92.70M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD -292,700 2019-03-31 2019 Q2 10-Q 2019-05-09 0001615774-19-007324
us-gaap CommonStockValue Common Stock, Value, Issued USD 93,000 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 1,091 2014-06-30 2014 Q3 10-Q 2014-08-13 0001062993-14-004769
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 7,000 2022-10-01 2023-09-30 2024 FY 10-K 2024-12-23 0001731122-24-002041
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 167,415 2015-10-01 2016-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 1,162 2015-10-01 2015-12-31 2017 Q1 10-Q 2017-02-07 0001615774-17-000400
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 332 2015-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 7.44M 2014-10-01 2015-09-30 2017 FY 10-K 2017-12-11 0001615774-17-007272
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 1 2016-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap DebtInstrumentConvertibleNumberOfEquityInstruments Debt Instrument, Convertible, Number of Equity Instruments Number 7.27M 2014-10-01 2015-09-30 2017 FY 10-K 2017-12-11 0001615774-17-007272
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 6,162 2015-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 5,830 2015-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs USD 0 2019-10-01 2020-09-30 2020 FY 10-K 2020-12-28 0001731122-20-001338
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 151,133 2019-06-30 2019 Q3 10-Q 2019-08-07 0001213900-19-014791
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 24,508 2020-06-30 2020 Q3 10-Q 2020-08-06 0001731122-20-000807
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 101,133 2018-09-30 2019 FY 10-K 2019-12-16 0001731122-19-000784
us-gaap DeferredIncomeCurrent Deferred Income, Current USD 805,000 2025-06-30 2025 Q3 10-Q 2025-08-12 0001731122-25-001105
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 7,000 2022-10-01 2023-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap DeferredRentCredit Deferred Rent Credit USD 805,000 2026-03-31 2026 Q2 10-Q 2026-08-28 0001731122-26-001166
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 946,000 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 20.70M 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 5.29M 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2020-09-30 2020 FY 10-K 2020-12-28 0001731122-20-001338
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 54.75M 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 76.80M 2020-09-30 2020 FY 10-K 2020-12-28 0001731122-20-001338
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 103.10M 2020-09-30 2020 FY 10-K 2020-12-28 0001731122-20-001338
us-gaap DeferredTaxAssetsOtherLossCarryforwards Deferred Tax Assets, Other Loss Carryforwards USD 64.00M 2019-09-30 2019 FY 10-K 2019-12-16 0001731122-19-000784
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 800,000 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 23.18M 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap DeferredTaxAssetsUnrealizedCurrencyLosses Deferred Tax Assets, Unrealized Currency Losses USD 49,000 2023-09-30 2023 FY 10-K 2023-11-27 0001731122-23-002197
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 108.49M 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap DeferredTaxAssetsValuationAllowanceCurrent Deferred Tax Assets, Valuation Allowance, Current USD 3.90M 2019-09-30 2019 FY 10-K 2019-12-16 0001731122-19-000784
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 52,396 2018-09-30 2019 FY 10-K 2019-12-16 0001731122-19-000784
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 746 2014-10-01 2015-06-30 2015 Q3 10-Q 2015-08-14 0001062993-15-004580
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1,252 2015-10-01 2016-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -567,000 2014-10-01 2015-06-30 2015 Q3 10-Q 2015-08-14 0001062993-15-004580
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2012-09-30 2012 FY 10-K 2012-12-31 0001062993-12-005603
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2014-06-30 2014 Q3 10-Q 2014-08-13 0001062993-14-004769
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 59.33M 2015-06-30 2015 Q3 10-Q 2015-08-14 0001062993-15-004580
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.03 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.14 2021-10-01 2021-12-31 2022 Q1 10-Q 2022-02-09 0001731122-22-000196
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.03 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.35 2017-10-01 2017-12-31 2017 Q1 10-Q 2018-02-07 0001615774-18-000934
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.21 2017-10-01 2017-12-31 2017 Q1 10-Q 2018-02-07 0001615774-18-000934
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 165,000 2022-10-01 2023-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.21 2017-10-01 2018-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap EffectOfExchangeRateOnCash Effect of Exchange Rate on Cash USD 216,000 2020-10-01 2021-09-30 2021 FY 10-K 2021-11-24 0001731122-21-002062
us-gaap EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet Embedded Derivative, Gain (Loss) on Embedded Derivative, Net USD -567,000 2014-10-01 2015-09-30 2017 FY 10-K 2017-12-11 0001615774-17-007272
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 5.08M 2020-10-01 2021-06-30 2021 Q3 10-Q 2021-08-12 0001731122-21-001347
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 1.20M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 29,000 2014-10-01 2015-09-30 2017 FY 10-K 2017-12-11 0001615774-17-007272
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2015-10-01 2016-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.013 2015-10-01 2016-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap FinancingInterestExpense Financing Interest Expense USD 47,408 2004-01-23 2013-12-31 2014 Q1 10-Q 2014-02-14 0001062993-14-000839
us-gaap FinancingReceivable Financing Receivable (Deprecated 2012-01-31) USD 35,810 2011-12-31 2012 Q1 10-Q 2012-02-14 0001062993-12-000506
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD -3,065 2015-10-01 2016-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 46,000 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -3,065 2015-10-01 2016-09-30 2017 FY 10-K 2017-12-11 0001615774-17-007272
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 199,655 2013-10-01 2014-09-30 2015 FY 10-K 2015-12-29 0001615774-15-003756
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 59,000 2023-10-01 2024-06-30 2024 Q3 10-Q 2024-08-06 0001731122-24-001207
us-gaap GainsLossesOnRestructuringOfDebt Gains (Losses) on Restructuring of Debt USD 0 2019-10-01 2020-09-30 2020 FY 10-K 2020-12-28 0001731122-20-001338
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 4.42M 2025-10-01 2026-03-31 2026 Q2 10-Q 2026-08-28 0001731122-26-001166
us-gaap GeneralInsuranceExpense General Insurance Expense USD 91,246 2004-01-23 2013-12-31 2014 Q1 10-Q 2014-02-14 0001062993-14-000839
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -44.50M 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -46.38M 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -1.88M 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -47.62M 2021-10-01 2022-09-30 2022 FY 10-K 2022-11-28 0001731122-22-002062
us-gaap IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net USD -3.18M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 995,000 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2021-10-01 2022-09-30 2022 FY 10-K 2022-11-28 0001731122-22-002062
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 18,000 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap IncomeTaxReceivable Income Taxes Receivable USD 1.87M 2018-09-30 2019 FY 10-K 2019-12-16 0001731122-19-000784
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 15.19M 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-23 0001731122-24-002041
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 216,000 2020-10-01 2021-09-30 2023 FY 10-K 2023-11-27 0001731122-23-002197
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -61,000 2023-10-01 2024-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -9.74M 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 5.30M 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 202,000 2013-10-01 2014-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 130,000 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 182,000 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -4.67M 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -593,000 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 451,981 2018-10-01 2019-06-30 2019 Q3 10-Q 2019-08-07 0001213900-19-014791
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 53,143 2018-10-01 2019-06-30 2019 Q3 10-Q 2019-08-07 0001213900-19-014791
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -661,000 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 443,831 2020-10-01 2021-06-30 2021 Q3 10-Q 2021-08-12 0001731122-21-001347
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD -37,396 2018-10-01 2019-06-30 2019 Q3 10-Q 2019-08-07 0001213900-19-014791
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD 186,000 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 772,388 2018-10-01 2019-09-30 2019 FY 10-K 2019-12-16 0001731122-19-000784
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 389,000 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 11.54M 2020-10-01 2021-09-30 2021 FY 10-K 2021-11-24 0001731122-21-002062
us-gaap InformationTechnologyAndDataProcessing Information Technology and Data Processing USD 200,489 2004-01-23 2013-12-31 2014 Q1 10-Q 2014-02-14 0001062993-14-000839
us-gaap InterestExpense Interest Expense USD -4,206 2015-10-01 2016-03-31 2016 Q2 10-Q 2016-05-11 0001615774-16-005331
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 3.21M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 14,625 2004-01-23 2014-03-31 2014 Q2 10-Q/A 2014-05-30 0001062993-14-003434
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 30,070 2022-10-01 2022-12-31 2023 Q1 10-Q 2023-02-07 0001731122-23-000152
us-gaap LegalFees Legal Fees USD 879,161 2004-01-23 2013-12-31 2014 Q1 10-Q 2014-02-14 0001062993-14-000839
us-gaap Liabilities Liabilities USD 7.69M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 120.14M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap LiabilitiesCurrent Liabilities, Current USD 9.48M 2022-06-30 2022 Q3 10-Q 2022-08-09 0001731122-22-001301
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2022-09-30 2022 FY 10-K 2022-11-28 0001731122-22-002062
us-gaap LongTermDebt Long-term Debt USD 332 2015-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 332 2015-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap MarketingExpense Marketing Expense USD 746,207 2004-01-23 2012-03-31 2012 Q2 10-Q 2012-05-15 0001062993-12-001798
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 36.44M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 22.43M 2016-10-01 2017-06-30 2017 Q3 10-Q 2017-08-07 0001615774-17-004118
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2014-10-01 2015-06-30 2015 Q3 10-Q 2015-08-14 0001062993-15-004580
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -3,015 2013-10-01 2014-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -20.69M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -6.83M 2016-10-01 2017-06-30 2017 Q3 10-Q 2017-08-07 0001615774-17-004118
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -3.19M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -3.18M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap NoninterestBearingDepositLiabilities Noninterest-bearing Deposit Liabilities USD 57,962 2015-06-30 2015 Q3 10-Q 2015-08-14 0001062993-15-004580
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 3.35M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap NotesPayableCurrent Notes Payable, Current USD 85,238 2015-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap OperatingExpenses Operating Expenses USD 6.53M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -6.53M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap OperatingLeaseCost Operating Lease, Cost USD 112,000 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap OperatingLeasePayments Operating Lease, Payments USD 70,022 2017-10-01 2018-09-30 2019 Q1 10-Q 2019-02-07 0001615774-19-002057
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 70,022 2018-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 28,047 2017-06-30 2017 Q3 10-Q 2017-08-07 0001615774-17-004118
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears Operating Leases, Future Minimum Payments Receivable, in Three Years USD 57,594 2017-12-31 2017 Q1 10-Q 2018-02-07 0001615774-18-000934
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 70,022 2018-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year USD 34,232 2017-09-30 2018 Q3 10-Q 2018-08-09 0001615774-18-007805
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 12.10M 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap OtherAccountsPayableAndAccruedLiabilities Other Accounts Payable and Accrued Liabilities USD 2.20M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.04M 2025-06-30 2025 Q3 10-Q 2025-08-12 0001731122-25-001105
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 1.62M 2014-10-01 2015-06-30 2015 Q3 10-Q 2015-08-14 0001062993-15-004580
us-gaap OtherGeneralExpense Other General Expense USD 30,648 2004-01-23 2013-12-31 2014 Q1 10-Q 2014-02-14 0001062993-14-000839
us-gaap OtherIncome Other Income USD 3.35M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 2,828 2015-10-01 2015-12-31 2016 Q1 10-Q 2016-02-08 0001615774-16-004126
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 504,160 2004-01-23 2014-03-31 2014 Q2 10-Q/A 2014-05-30 0001062993-14-003434
us-gaap OtherNonoperatingGainsLosses Other Nonoperating Gains (Losses) USD -3.59M 2014-10-01 2015-06-30 2015 Q3 10-Q 2015-08-14 0001062993-15-004580
us-gaap OtherReceivables Other Receivables USD 800,000 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap OtherShortTermInvestments Other Short-term Investments USD 15,000 2019-06-30 2019 Q3 10-Q 2019-08-07 0001213900-19-014791
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD -4.23M 2017-10-01 2017-12-31 2017 Q1 10-Q 2018-02-07 0001615774-18-000934
us-gaap PaymentsForDelayedTaxExemptExchange Payments for Delayed Tax Exempt Exchange USD 2.71M 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2019-10-01 2020-09-30 2020 FY 10-K 2020-12-28 0001731122-20-001338
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 706,802 2021-10-01 2022-06-30 2023 Q3 10-Q 2023-08-08 0001731122-23-001412
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 707,000 2021-10-01 2022-09-30 2023 FY 10-K 2023-11-27 0001731122-23-002197
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 8.85M 2025-10-01 2026-03-31 2026 Q2 10-Q 2026-08-28 0001731122-26-001166
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 0 2014-10-01 2015-06-30 2015 Q3 10-Q 2015-08-14 0001062993-15-004580
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 3,015 2013-10-01 2014-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap PensionContributions Payment for Pension Benefits USD 150,000 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2025-06-30 2025 Q3 10-Q 2025-08-12 0001731122-25-001105
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 818,000 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 355,549 2021-09-30 2021 FY 10-K 2021-11-24 0001731122-21-002062
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 10.00M 2013-10-01 2014-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 11.28M 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-23 0001731122-24-002041
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2013-10-01 2014-09-30 2014 FY 10-K 2014-12-29 0001062993-14-007294
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 33,665 2004-01-23 2014-03-31 2014 Q2 10-Q/A 2014-05-30 0001062993-14-003434
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 6,000 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1.47M 2020-10-01 2021-09-30 2023 FY 10-K 2023-11-27 0001731122-23-002197
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 12.07M 2004-01-23 2013-12-31 2014 Q1 10-Q 2014-02-14 0001062993-14-000839
us-gaap ProfessionalFees Professional Fees USD 872,197 2004-01-23 2013-12-31 2014 Q1 10-Q 2014-02-14 0001062993-14-000839
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -33.69M 2021-10-01 2022-06-30 2022 Q3 10-Q 2022-08-09 0001731122-22-001301
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1,252 2015-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap ReceivableFromOfficersAndDirectorsForIssuanceOfCapitalStock Receivable from Officers and Directors for Issuance of Capital Stock USD -2.00M 2015-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap RedemptionPremium Redemption Premium USD 9.20M 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party USD 3.04M 2015-10-01 2015-12-31 2016 Q1 10-Q 2016-02-08 0001615774-16-004126
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 34,759 2015-10-01 2016-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned Research and Development Arrangement, Contract to Perform for Others, Compensation Earned USD 90,000 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 8.85M 2025-10-01 2026-03-31 2026 Q2 10-Q 2026-08-28 0001731122-26-001166
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -385.64M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 684,794 2015-10-01 2016-06-30 2016 Q3 10-Q 2016-08-11 0001615774-16-006697
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 1.13M 2004-01-23 2013-12-31 2014 Q1 10-Q 2014-02-14 0001062993-14-000839
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 2.38M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD -15.66M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 4.73 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.866 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 250,000 2015-09-30 2015 FY 10-K 2015-12-29 0001615774-15-003756
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 160,000 2024-03-31 2024 Q2 10-Q 2024-05-09 0001731122-24-000760
us-gaap SharePrice Share Price USD/shares 1 2015-09-30 2017 FY 10-K 2017-12-11 0001615774-17-007272
us-gaap SharesHeldInEmployeeStockOptionPlanSuspenseShares Shares held in Employee Stock Option Plan, Suspense Shares shares 205,000 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap SharesIssued Shares, Issued shares 6.03M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 1.2 2015-09-30 2017 FY 10-K 2017-12-11 0001615774-17-007272
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 610,000 2015-10-01 2016-09-30 2016 FY 10-K 2016-12-14 0001615774-16-008914
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 112.45M 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.90M 2017-10-01 2018-06-30 2018 Q3 10-Q 2018-08-09 0001615774-18-007805
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 4 2015-10-01 2016-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 24.11M 2020-10-01 2021-09-30 2021 FY 10-K 2021-11-24 0001731122-21-002062
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 6,162 2015-10-01 2016-09-30 2018 FY 10-K 2019-01-25 0001615774-19-001031
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 24.11M 2020-10-01 2021-06-30 2021 Q3 10-Q 2021-08-12 0001731122-21-001347
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 20.98M 2021-10-01 2022-06-30 2023 Q3 10-Q 2023-08-08 0001731122-23-001412
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 11.28M 2023-10-01 2024-06-30 2024 Q3 10-Q 2024-08-06 0001731122-24-001207
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 610,000 2015-10-01 2015-12-31 2016 Q1 10-Q 2016-02-08 0001615774-16-004126
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.01M 2021-10-01 2022-06-30 2022 Q3 10-Q 2022-08-09 0001731122-22-001301
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares -75,000 2008-10-01 2009-09-30 2011 FY 10-K 2011-12-22 0001062993-11-005004
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 11.28M 2023-10-01 2024-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap TaxesExcludingIncomeAndExciseTaxes Taxes, Miscellaneous USD 358,000 2021-10-01 2022-09-30 2023 FY 10-K 2023-11-27 0001731122-23-002197
us-gaap TravelAndEntertainmentExpense Travel and Entertainment Expense USD 772,874 2004-01-23 2013-12-31 2014 Q1 10-Q 2014-02-14 0001062993-14-000839
us-gaap UnamortizedLossReacquiredDebtNoncurrent Unamortized Loss Reacquired Debt, Noncurrent USD 16,365 2021-09-30 2021 FY 10-K 2021-11-24 0001731122-21-002062
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 16.30M 2024-10-01 2025-09-30 2025 FY 10-K/A 2026-08-28 0001731122-26-001164
us-gaap ValueAddedTaxReceivableCurrent Value Added Tax Receivable, Current USD 0 2012-09-30 2012 FY 10-K 2012-12-31 0001062993-12-005603
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 91.45B 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 76.00M 2021-10-01 2021-12-31 2022 Q1 10-Q 2022-02-09 0001731122-22-000196
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 91.45B 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-28 0001731122-26-001167

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →